Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
FDA advisory committee votes 10-8 in favor of ChemoCentryx's experimental drug; stock is down
10:14am, Friday, 07'th May 2021
Shares of ChemoCentryx Inc. tumbled 61.7% in trading on Friday, the day after a Food and Drug Administration advisory committee voted 10-8 that the benefits of the company's experimental autoimmune dr
Boston, Massachusetts--(Newsfile Corp. - May 7, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, announces that has filed a class action lawsuit on behalf of
CCXI INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud
09:35am, Friday, 07'th May 2021
SAN FRANCISCO, May 7, 2021 /PRNewswire/ -- Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is pendi
Adcomm Split On FDA Approval For ChemoCentryx's Vasculitis Candidate
06:47am, Friday, 07'th May 2021
The FDA's Arthritis Advisory Committee voted 10 for and 8 against the approval of ChemoCentryx Inc's (NASDAQ: CCXI) investigational drug avacopan as a treatment for adults with a rare and serious
ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis
11:37pm, Thursday, 06'th May 2021
SAN CARLOS, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the outcome of the U.S. Food and Drug Administration (“FDA”) Arthritis Advisory Committee (
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 6, 2021 to file
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #CCXI--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc.
The Law Offices of Frank R. Cruz Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors
05:17pm, Thursday, 06'th May 2021
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #investors--The Law Offices of Frank R. Cruz Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ChemoCentryx, Inc. (CCXI) on Behalf of Investors
03:05pm, Thursday, 06'th May 2021
BENSALEM, Pa.--(BUSINESS WIRE)---- $CCXI #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) (NASDAQ: CCXI
New York, New York--(Newsfile Corp. - May 6, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securit
CCXI INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against ChemoCentryx, Inc.
01:20pm, Thursday, 06'th May 2021
NEW YORK, May 6, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who pu
RADNOR, Pa., May 6, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (NASDAQ: C
Los Angeles, California--(Newsfile Corp. - May 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ChemoC
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of ChemoCentryx, Inc. (NASDA
Boston, Massachusetts--(Newsfile Corp. - May 6, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it has filed a class action lawsuit on
